PairX Bio
Manufacturing · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Biopolis Rd, Singapore, Central Singa...Website
www.pairxbio.comRevenue
<$5 MillionIndustry
About PairX Bio
PairX Bio Org Chart
Is PairX Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
PairX Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if PairX Bio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once PairX Bio has new funding data
Check if PairX Bio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on PairX Bio recently announced quarterly report
Product Launch: Get notified when PairX Bio launches new products
Check out if PairX Bio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at PairX Bio
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined PairX Bio as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
PairX Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PairX Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PairX Bio.
PairX Bio Tech Stack
A closer look at the technologies used by PairX Bio
PairX Bio News & Media
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PairX Bio
PairX Bio is focused on developing next-generation cancer immunotherapies that target shared tumor-associated antigens derived from aberrantly spliced proteins. The company utilizes a biology-driven, variant-specific approach to identify novel, highly prevalent, tumor-selective cell surface variants, aiming to create highly selective drugs that min... Read More